In this study we investigated the agewise distributions of , we found that some 30% of a group of 169 diabetic patients had high serum IgA concentrations, the same prevalence holding among both insulin-depen-
In an earlier study [1] , we found that immunoglobulin A (IgA) has a marked effect on fructosamine determinations: 80% of a group of nondiabetics with abnormally high IgA concentrations but no hepatic disease had abnormally high fructosamine concentrations.
Subsequently [2] , we found that some 30% of a group of 169 diabetic patients had high serum IgA concentrations, the same prevalence holding among both insulin-depen- higher than in 54 healthy subjects (2.1 ± 0.8 gIL) or 149 nondiabetic patients (2.3 ± 0.9 gIL), and the difference was maintained regardless of whether the diabetic patients had kidney disease (3.5 ± 1.6 g/L, n = 50), liver disease (3.7 ± 2.1 g/L, n = 15), both (3.6 ± 1.7 g/L, n = 65), or neither (3.4 ± 1.6 g/L, n = 84).
To confirm the association between diabetes and high serum IgA concentration, and bearing in mind the statistically significant differences among the serum IgA concentrations of healthy subjects of different age groups [4] , in this study we determined the agewise distribution of circulating IgA concentration in broad samples of control subjects and diabetic patients of both types. We also studied whether high IgA concentrations were associated with microvascular and (or) macrovascular diabetic complications.
Materials and Methods

SUBJECTS
The diabetic outpatient clinics at the Galician General Hospital, exhibitedretinal microaneurysms, soft exudates, small intraretinal hemorrhages, venous bleeding,neovascularization, or retinal traction or detachment. The presence of retinopathywas determined by an experienced observer by direct ophthalmoscopy through pupils dilated with 5 g/L tropicamide.
Neuropathy.Vibration thresholds
at both medial malleoli and both great toes were determined by using a biothesiometer (Biomedical Instrument Co., Newbury, OH); neuropathy was considered to be present if the thresholds were >2 above the mean of the control subjects of the same age group [7] . Neuropathy was also diagnosed when there were symptoms compatible with sensorimotor polyneuropathy, autonomic neuropathy or mononeuropathy, absent ankle reflexes, or impairment of light touch or pin-prick sensation in the feet.
Nephropathy.
Patients were considered nephropathic if they exhibited proteinuria of 1 g/L (or 0.3 g/L on more than one occasion) in the absence of infection and of any evident cause of renal disease other than diabetes. 
Results
SERUM IGA CONCENTRATIONS Table 1 lists the serum IgA concentrations (median and reference range; see Material and Methods) in each age group of the 943 control subjects, together with the median and range in each age group of the 1251 type I patients and the 2224 type 2 patients. Fig. 1 shows the frequency distributions of IgA concentrations among type 1 and type 2 diabetic patients. The observed reference ranges are similar to those reported by other authors who used an analytical method similar to ours [4] . The overall median among the control subjects was 1.46 g/L (range 0.22-3.89 g/L); in no age group was there a statistically significant difference between male and female controls.
The overall median among type 1 patients was 2.01 g/L (range 0.29-7.01 g/L), and the overall median among type 2 patients was 2.67 g/L (range 0.67-9.86 g/L). These values differed significantly from the median for control subjects (P <0.005 for type 1, P <0.00 1 for type 2). Type 1 and type 2 age groups had significantly higher IgA concentrations than the control groups, except for the type 1 patients ages <20 years and >60 years, and the type 2 patients ages <50 years, keeping in mind the Bonferroni criterion. Among type 1 patients the greatest difference occurred for the 41-50-year-old age group, which had a median IgA concentration 71% higher than that of the control group, whereas among type 2 patients the greatest difference occurred for the 51-60-year-old group, whose median IgA concentration was 65% higher than that of the control group.
High serum IgA concentrations were exhibited by 2 1.3% of type I diabetic patients and by 24.1% of type 2 patients. High Rodriguez-Segade et al.: Serum IgA in diabetes mellitus patients Arrows indicate the upper limits of the reference ranges for subjects ages <60 years (3.1 g/L) and >60 years (3.9 g/L). Among both type 1 and type 2 patients, the group with all three microvascular complications had higher IgA concentrations
IgA was significantly more common among males than among than the group with just one complication. females for type 1 patients, among whom 24.4% of males and
The groups with the highest proportions of members with 18% of females had high IgA.
high IgA were the neuropathy group for type 1 patients (31.9%) and the macroangiopathy group for type 2 patients (27.3%). Table 2 lists the serum IgA concentrations of various patient The results of this study of a rather large sample of diabetic subgroups defined on the basis of their micro-or macrovascular patients confirm the high average serum IgA concentrations [8] found that self-antibodies of all immunoglobulin classes against the specific epitope 4-furanoyl-2 -furoyl-1H-imidazole-l-hexanoic acid (FF1) are common in both healthy and diabetic persons, but that FF1-specific IgA differed from FF1-specific IgG and 1gM in that its mean titer in diabetic sera was significantly higher than its mean titer in healthy sera. This suggests that high IgA concentrations in diabetic patients are the result of an immune response to advanced glycosylation end products. It also suggests that the prevalence of high IgA among diabetics might be considerably higher than the overall 23% found in this study if "high IgA" is defined in terms of some relevant specific IgA or IgA subclass rather than as total IgA.
ASSOCIATION BETWEEN
HIGH IGA AND DIABETIC
COMPLICATIONS DiSCUSSiON
In conclusion, this study confirms that increased concentrations of circulating IgA are general among both type 1 and type 2 diabetic patients, that this phenomenon is more marked among males than among females, and that high serum IgA is a nonspecific sign of the development of diabetic complications.
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